Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Bishoy Faltas, Assistant Professor of Medicine at Weill Cornell Medical College. Together they discuss bladder cancer, the evolution of the disease, and the latest research being conducted to improve the outcomes of patients.

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Soo Park, Assistant Professor in the Division of Hematology-Oncology at UC San Diego Health. Together they discuss how precision medicine and molecular profiling have shaped the way we care for patients with cutaneous cancers.

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Advance Practice Providers Kathryn Simon and Sarah Wyman from the Winship Cancer Institute at Emory University. Together they discuss the impact and contributions Advance Practice Providers make to oncology care in the era of precision medicine.

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Milan Radovich, Senior Vice President and Chief Precision Medicine Officer at Caris Life Sciences. Together they discuss the future of precision medicine, how precision oncology is evolving into the earlier stages of disease, and the paradigm shifts to look for in the overall survival of cancer.

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Emil Lou, Associate Professor of Medicine in the Division of Hematology, Oncology and Transplantation at the University of Minnesota. Together they discuss the challenges in gastrointestinal cancer and how liquid biopsies are applied within these malignancies.

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Elisabeth Heath, Professor of Oncology and Associate Center Director, Translational Sciences, at the Karmanos Cancer Institute. Together they discuss the advances and future of liquid biopsies and their clinical utilization within genitourinary cancers.

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephen Liu, Associate Professor of Medicine at Georgetown University and Director of Thoracic Oncology at the Georgetown Lombardi Comprehensive Cancer Center. Together they discuss liquid biopsies and their utilization in thoracic malignancies.

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. David Spetzler, President and Chief Scientific Officer at Caris Life Sciences®, to discuss the latest advances in liquid biopsies, the clinical utility of these offerings, and how precision oncology is leveraging this new source of molecular information to improve patient outcomes.

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Jimmy Hwang, Chief, GI Medical Oncologist at the Levine Cancer Institute. Dr. Hwang recently contributed to a JCO publication titled, “Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.” Together, Dr. Nabhan and Dr. Hwang discuss the recommendations made in this article and the impact genomic testing can have on patient outcomes.

To access this article, please visit: https://ascopubs.org/doi/full/10.1200/JCO.21.02767

For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Jamie Holloway, Area Vice President, Molecular Science Liaison at Caris Life Sciences. Together, they take a closer look at the Caris Report and explain how its results aid oncologists in personalizing cancer therapies for their patients.

For more information, please visit: www.CarisLifeSciences.com